IPO Ideas

Go to page

Browse IPO Ideas — market data, blogs, legal pages, and more.

Amanta Healthcare Limited IPO logo

Amanta Healthcare Limited IPO

BBMainboardBSE, NSEListed
Listed at
135
+7.14%

Amanta Healthcare Limited IPO is a Mainboard book building IPO. Price band is ₹120 to ₹126 per share. Minimum investment is ₹14,994. Lot size is 119 shares. Open from 1 Sept 2025 to 3 Sept 2025. Allotment on 4 Sept 2025. Listing on 9 Sept 2025 at BSE, NSE. Managed by Beeline Capital Advisors Pvt.Ltd. Registrar: MUFG Intime India Private Limited (Link Intime). Key details for GMP, subscription, price, allotment, and listing in one place.

Official documents: RHP and DRHP.

Amanta Healthcare Limited IPO overview

Amanta Healthcare Limited IPO Key figures

Price band, lot, minimum application, and issue window at a glance.

Price band
₹120 to ₹126
Lot size
119 shares / lot
Min investment
₹14,994
Issue open – close
1 Sept 2025 → 3 Sept 2025

Amanta Healthcare Limited IPO important dates

Issue Opens
1 Sept 2025
Issue Closes
3 Sept 2025
Allotment
4 Sept 2025
Listing
9 Sept 2025

Amanta Healthcare Limited IPO lot size

CategoryLotsSharesAmount
Retail (Min)111914,994
Retail (Max)131,5471,94,922
S-HNI (Min)141,6662,09,916
S-HNI (UPI)333,9274,94,802
S-HNI (Max)667,8549,89,604
B-HNI (Min)677,97310,04,598

About Amanta Healthcare Limited IPO

From the company / RHP narrative.

Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products, specifically parenteral products, which are packaged in plastic containers utilizing Aseptic Blow-Fill-Seal (“ABFS”) and Injection Stretch Blow Moulding (“ISBM”) technologies. The company is also a manufacturer of medical devices.

The company manufactures fluid therapy formulations, including IV fluids, diluents, ophthalmic solutions, and respiratory care products. It also offers irrigation solutions, first-aid products, and eye lubricants in the medical device segment.

The company markets products through three business units:


National sales,
International sales and
Product partnering with various foreign and Indian pharmaceutical companies.


The company manufactures over 45 generic products, marketing them under their brands in India through 320 distributors and stockists.

The company sells products in Africa, Latin America, the UK, and beyond. Its products are registered in 19 countries and comply with various regulations. In Fiscal 2025, the company exported branded products to 21 countries.

As of March 31, 2025, the company has a team of 1,718 employees at its formulation and development and quality laboratory.

 

Competitive Strengths


Well-established manufacturer of pharmaceutical formulations with a diverse product portfolio and diverse market.
Large manufacturing capabilities
Wide Domestic and International Marketing Network.

Experienced management team supported by a large, diverse and skilled workforce.

Objective of the issue

How the issuer plans to use IPO proceeds.

Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat

Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat

General corporate purposes
Amanta Healthcare Limited IPO FAQs
A quick overview of key terms, dates, and how to track this IPO.

Ratings & reviews

Community ratings and reviews — not financial advice.

No ratings yet — be the first to share your experience.

Loading ratings…

Follow the latest IPO & unlisted research on iOS and Android.

Documents & links

Prospectus, draft filings, and company site open in a new tab.

Registrar

Details about the registrar of the issue.

Registrar Name
MUFG Intime India Private Limited (Link Intime)
Phone
2249186270
Address
Link Intime India Private Ltd C 101, 247 Park, L.B.S.Marg, Vikhroli (West), Mumbai - 400083

Issue details

Key details about the issue, including the face value, lot size, and minimum investment.

Issue Type
BB
Face Value
10
Lead Managers
Beeline Capital Advisors Pvt.Ltd.
Min Quantity
119
Company Promoters
Bhavesh Patel,Vishal Patel,Jayshreeben Patel,Jitendra Kumar Patel,Milcent Appliances Private Limited.
Phone
079 67777600
Address
Amanta Healthcare Ltd. 8th Floor, Shaligram Corporates C.J. Marg Ambli, Ahmedabad, Gujarat, 380058

Related articles

Research posts and updates that reference this company or theme.

Follow the latest IPO & unlisted research on iOS and Android.